AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures

Neurobiology of Disease

Volumn 6, Issue 6, 1999, Pages 475-485

  Sánchez Gómez, María Victoria ^a   Matute, Carlos ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; CALCIUM ION; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; RECEPTOR SUBUNIT;

ANIMAL CELL; ARTICLE; CALCIUM CONDUCTANCE; CELL VIABILITY; CONTROLLED STUDY; DEMYELINATING DISEASE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PRIORITY JOURNAL; RAT;

EID: 0343776133     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1999.0264     Document Type: Article

References (43)

1. Barres B. A., Hart I. K., Coles H. S. R., Burne J. F., Voyvodic J. T., Richardson W. D., Raff M. C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70:1992;31-46.
2. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J. Neurosci. 14:1994;187-197.
3. Brorson J. R., Manzolillo P. A., Gibbsons S. J., Miller R. J. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J. Neurosci. 15:1995;4515-4524.
4. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1:1991;163-175.
5. Burnashev N. Calcium permeability of glutamate-gated channels in the central nervous system. Curr. Opin. Neurobiol. 6:1996;311-317.
6. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-624.
7. Choi D. W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
8. Choi D. W. Calcium: Still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:1995;58-60.
9. Choi D. W., Koh J. Y., Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J. Neurosci. 8:1988;185-196.
10. Coyle J. T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 269:1993;689-695.
11. Domercq M., Matute C. Expression of glutamate transporters in the adult corpus callosum. Mol. Brain Res. 67:1999;296-302.
12. Domercq M., Sánchez-Gómez M. V., Areso P., Matute C. Expression of glutamate transporters in rat optic nerve oligodendrocytes. Eur. J. Neurosci. 11:1999;2226-2236.
13. Egebjerg J., Bettler B., Hermans-Borgmeyer I., Heinemann S. F. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature. 351:1991;745-748.
14. García-Barcina J., Matute C. Expression of kainate-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Eur. J. Neurosci. 8:1996;2379-2387.
15. García-Barcina J., Matute C. AMPA-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Mol. Brain Res. 53:1998;270-276.
16. Gottlieb M., Matute C. Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischemia. J. Cereb. Blood Flow Metab. 17:1997;290-300.
17. Hollmann M., Heinemann S. F. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
18. Huettner J. E. Glutamate receptor channels in rat DRG neurons - Activation by kainate and quisqualate and blockade of desensitization by Con-A. Neuron. 5:1990;255-266.
19. Jones K. H., Senft J. A. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J. Histochem. Cytochem. 33:1985;77-79.
20. Kinney H. C., Armstrong D. D. Perinatal neuropathology. Graham D. I., Lantos P. L. Greenfield's Neuropathology. 1997;537-600 Arnold, London.
21. Lerma J. Kainate reveals its targets. Neuron. 19:1997;1155-1158.
22. Lipton S. A. Neuronal injury associated with HIV-1: Approaches to treatment. Annu. Rev. Pharmacol. Toxicol. 38:1998;159-177.
23. Lipton S. A., Rosenberg P. A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
24. Matute C. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc. Natl. Acad. Sci. USA. 95:1998;10229-10234.
25. Matute C., Sánchez-Gómez M. V., Martínez-Millán L., Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl. Acad. Sci. USA. 94:1997;8830-8835.
26. McDonald J. W., Althomsons S. P., Hyrc K. L., Choi D. W., Goldberg M. P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 4:1998;291-297.
27. Michaelis E. K. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54:1998;369-415.
28. Oka A., Belliveau M. J., Rosenberg P. A., Volpe J. J. Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention. J. Neurosci. 13:1993;1441-1453.
29. Paternain A. V., Morales M., Lerma J. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron. 14:1995;185-189.
30. Paternain A. V., Rodríguez-Moreno A., Villarroel A., Lerma J. Activation and desensitization properties of native and recombinant kainate receptors. Neuropharmacology. 37:1998;1249-1259.
31. Patneau D. K., Vickliky L. Jr., Mayer M. L. Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. J. Neurosci. 13:1993;3496-3509.
32. Patneau D. K., Wright P. W., Winters C., Mayer M. L., Gallo V. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptors. Neuron. 12:1994;357-371.
33. Porter J. T., McCarthy K. D. Astrocytic neurotransmitter receptors in situ and in vivo. Prog. Neurobiol. 51:1997;439-455.
34. Puchalski R. B., Louis J. C., Brose N., Traynelis S. F., Egebjerg J., Kukekov V., Wenthold R. J., Rogers S. W., Lin F., Moran T., Morrison J. H., Heinemann S. F. Selective RNA editing and subunit assembly of native glutamate receptors. Neuron. 13:1994;131-147.
35. Rodríguez-Moreno A., Herreras O., Lerma J. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus. Neuron. 19:1997;893-901.
36. Rodríguez-Moreno A., Lerma J. Kainate receptor modulation of GABA release involves a metabotropic function. Neuron. 20:1998;1211-1218.
37. Rubinsztein D. C., Leggo J., Chiano M., Dodge A., Norbury G., Rossier E., Craufurd D. Genotypes of the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc. Natl. Acad. Sci. USA. 94:1997;3872-3876.
38. Schiffer H. H., Swanson G. T., Heinemann S. F. Rat GluR7 and a carboxy-terminal splice variant, GluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate. Neuron. 19:1997;1141-1146.
39. Steinhäuser C., Gallo V. News on glutamate receptors in glial cells. Trends Neurosci. 19:1996;339-345.
40. Stys P. K. Anoxic and ischemic injury of myelinated axons in CNS white matter: From mechanistic concepts to therapeutics. J. Cereb. Blood Flow Metab. 18:1998;2-25.
41. Volterra A., Trotti D., Tromba C., Floridi S., Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14:1994;2924-2932.
42. Wang Y., Small D. L., Stanimirovic D. B., Morley P., Durkin J. P. AMPA receptor-mediated regulation of a Gi-protein in cortical neurons. Nature. 389:1997;502-504.
43. Yoshioka A., Bacskai B., Pleasure D. Pathophysiology of oligodendroglial excitotoxicity. J. Neurosci. Res. 46:1996;427-437.